BACKGROUND ColonCancerCheck (CCC), Canada's first province-wide colorectal cancer screening program, was publicly launched in Ontario in April 2008. The objective of this article is to report on key indicators of CCC Program performance since its inception. METHODS The CCC Program recommends biennial guaiac-based fecal occult blood test (gFOBT) for persons 50 to 74 years of age at average ris...

BACKGROUND Data on the quality of colonoscopies in populations with rising colorectal cancer (CRC) incidence is scarce. We aimed to calculate the adenoma detection rates (ADR), and assess the quality of colonoscopies in an opportunistic screening colonoscopy program in Iran. METHODS All the colonoscopy and pathology reports of asymptomatic adults over age 50 who underwent screening colonoscop...

OBJECTIVES The Affordable Care Act eliminated patient cost sharing for evidence-based preventive care, yet the impact of this policy on colonoscopy and mammography rates is unclear. We examined the elimination of cost sharing among small business beneficiaries of Humana, a large national insurer. STUDY DESIGN This was a retrospective interrupted time series analysis of whether the change in c...

BACKGROUND The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is considering switching from biennial guaiac fecal occult blood test (gFOBT) screening between age 50-74 years to the more sensitive, but also less specific fecal immunochemical test (FIT). The aim of this study is to estimate whether the additional benefits of FIT screening compared to gFOBT outw...

www.thelancet.com/oncology Published online February 25, 2016 http://dx.doi.org/10.1016/S1470-2045(16)00139-X 1 Updated Canadian guidelines recommend that low-risk adults aged 50 to 74 years should be screened for colorectal cancer with faecal occult blood testing (FOBT) or faecal immunochemical testing (FIT) every 2 years, or fl exible sigmoidoscopy every 10 years, rather than colonoscopy. The...

Background and study aims Serrated polyposis syndrome (SPS) is a high risk condition for colorectal cancer (CRC). Surveillance strategies for patients with serrated lesions remain controversial. We aimed to evaluate a diagnostic strategy to detect SPS consistently during reassessment colonoscopy in patients with proximal serrated lesions. Methods This was a retrospective study of all individual...

background: colorectal cancer is the second cause of the cancer related mortalities in the world. screening can effectively reduce the mortality and morbidity rate of this cancer. sensitivity and specificity of screening methods play an important role in their efficacy. the aim of this study is to review sensitivity and specificity of selected colorectal cancer screening methods systematically....

PURPOSE A significant reduction in colorectal cancer (CRC) mortality is attributed to CRC screening and surveillance. However, there is no national consensus on CRC screening and surveillance in Thailand. The aim of this study was to assess current practice in CRC screening and surveillance among Thai general surgeons. METHODS Between July and November 2008, a questionnaire was randomly sent ...

OBJECTIVES To determine current colorectal cancer (CRC) screening rates and the level of adherence to screening guidelines @a community level. SETTING A cross-sectional cohort of at-risk people aged 56-88 years randomly selected from the Hunter Community Study (HCS), Australia. MAIN OUTCOME MEASURES Proportion ever reporting undertaking any CRC testing; current screening rates for each CRC ...

Colorectal cancer (CRC) is the third most common cancer worldwide. It is amenable to screening as it occurs in premalignant, latent, early, and curable stages. PubMed, Cochrane Database of Systematic Reviews, and national and international CRC screening guidelines were searched for CRC screening methods, populations, and timing. CRC screening can use direct or indirect tests, delivered opportun...